GO:0060298 positive regulation of sarcomere organization: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060298 describes any process that increases the rate, frequency or extent of sarcomere organization, the assembly of muscle actomyosin into repeating contractile units.
• Sarcomere organization is driven by self-organization of actin and myosin filaments, and positive regulators enhance this process through biophysical and biochemical cues.
• Key genes include sarcomeric structural proteins (MYH7, ACTC1, TNNT2, MYBPC1) and signaling regulators (RYR2, AMPK, mTOR) that modulate assembly.
• Dysregulation of sarcomere organization is linked to cardiomyopathies, skeletal myopathies, and neuromuscular disorders.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators in cardiomyocytes and skeletal muscle cells.
• Studying this process requires integration of imaging, transcriptomics, and functional assays to capture dynamic sarcomere assembly.
Description
GO:0060298, positive regulation of sarcomere organization, is a biological process that increases the rate, frequency or extent of myofibril assembly by organizing muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. This term is essential for understanding how muscle cells build and maintain their contractile machinery, and how perturbations lead to disease. Researchers study this process to identify molecular drivers of sarcomere assembly, to model muscle disorders, and to develop therapeutic strategies that enhance or restore contractile function.
positive regulation of sarcomere organization At A Glance
| GO ID | GO:0060298 |
|---|---|
| GO term | positive regulation of sarcomere organization |
| Ontology | biological_process |
| Synonym | positive regulation of sarcomere organisation |
| Major function | Increases the rate, frequency or extent of myofibril assembly by organizing muscle actomyosin into sarcomeres |
| Related process | Sarcomere organization (GO:0045214) |
| Cellular context | Muscle cells, including cardiomyocytes and skeletal myocytes |
| Disease relevance | Cardiomyopathies, skeletal myopathies, neuromuscular disorders |
What Is GO:0060298?
Positive regulation of sarcomere organization (GO:0060298) refers to any process that increases the rate, frequency or extent of myofibril assembly by organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. This regulation can occur through changes in gene expression, protein stability, post-translational modifications, or biophysical cues that promote the ordered assembly of sarcomeric components.
Why Is positive regulation of sarcomere organization Important in Cell Biology?
Understanding positive regulation of sarcomere organization is critical because sarcomeres are the fundamental contractile units of muscle, and their proper assembly is required for normal cardiac and skeletal muscle function. Defects in this process contribute to a range of human diseases, including hypertrophic and dilated cardiomyopathies, congenital myopathies, and age-related muscle dysfunction. Moreover, regenerative processes such as heart regeneration in model organisms depend on the re-differentiation of cardiomyocytes and reassembly of sarcomeres, highlighting the importance of positive regulators in tissue repair.
• Sarcomere organization is essential for muscle contraction and mechanical stability.
• Positive regulators enhance myofibril assembly during development and regeneration.
• Mutations in sarcomeric genes cause cardiomyopathies and myopathies.
• Biophysical cues can reprogram non-muscle cells toward cardiomyocyte-like sarcomere organization.
• Satellite cell dysfunction in neuromuscular disorders impairs muscle regeneration and sarcomere assembly.
• Ryanodine receptor signaling modulates calcium handling that influences sarcomere organization.
• Circulating miRNAs may serve as biomarkers for muscle-related pathologies.
• Environmental stressors can alter expression of muscle structural genes in marine organisms.
• Therapeutic targeting of positive regulators may improve muscle function in disease.
• CRISPR-based models enable precise dissection of regulatory mechanisms.
What Happens During positive regulation of sarcomere organization?
Initiation of myofibril assembly
In simple terms: Cells start building the contractile machinery by laying down early structural cues.
Positive regulation begins with the expression and localization of sarcomeric proteins such as actin and myosin, which self-organize into premyofibrils. Biophysical cues, including substrate stiffness and electrical stimulation, can accelerate this process in reprogrammed cells. The self-organization of muscle cell structure and function is an emergent property of these interactions.
Actin and myosin filament organization
In simple terms: Actin and myosin filaments line up in a precise overlapping pattern.
The core of sarcomere organization is the arrangement of actin thin filaments and myosin thick filaments into a repeating pattern between Z discs. Positive regulators enhance the rate and extent of this organization, often through signaling pathways that modulate cytoskeletal dynamics. In scallops, environmental pH and temperature changes alter expression of genes involved in muscle structure, indicating sensitivity of this process to external conditions.
Z-disc and M-band formation
In simple terms: Anchor points form to hold the filaments in place.
Z discs serve as anchors for actin filaments, while the M band cross-links myosin filaments. Positive regulation includes the timely incorporation of proteins such as titin, myomesin, and alpha-actinin. Mutations in MYBPC1, a sarcomeric protein, have been linked to myogenic tremor, underscoring the importance of proper Z-disc and M-band assembly.
Calcium signaling and excitation-contraction coupling
In simple terms: Calcium signals help coordinate contraction and assembly.
Ryanodine receptors mediate calcium release from the sarcoplasmic reticulum, which is essential for excitation-contraction coupling and can influence sarcomere organization. Positive regulators may enhance calcium handling to promote assembly and function.
Metabolic and energetic support
In simple terms: Energy supply supports the building and maintenance of sarcomeres.
Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term heart regeneration in fish, indicating that metabolic pathways positively regulate sarcomere organization during regeneration. AMPK and mTOR signaling are key energy sensors that can modulate protein synthesis and assembly.
Key Genes Involved in GO:0060298 positive regulation of sarcomere organization
The following genes and proteins are central to positive regulation of sarcomere organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Myosin heavy chain, thick filament component | Mutations cause hypertrophic cardiomyopathy; target for assembly studies |
| ACTC1 | Actin, thin filament component | Essential for sarcomere formation; mutated in cardiomyopathies |
| TNNT2 | Troponin T, regulates calcium-dependent contraction | Linked to dilated cardiomyopathy; affects sarcomere stability |
| MYBPC1 | Myosin binding protein C, modulates thick filament | Variants cause myogenic tremor; model for sarcomere assembly |
| RYR2 | Ryanodine receptor, calcium release channel | Regulates calcium signaling for contraction; studied in arrhythmias |
| TTN | Titin, molecular spring and scaffold | Mutations cause dilated cardiomyopathy; key for sarcomere elasticity |
| MYL2 | Regulatory myosin light chain | Modulates myosin activity; implicated in cardiomyopathy |
| TPM1 | Tropomyosin, thin filament regulation | Mutations linked to hypertrophic cardiomyopathy |
| ACTN2 | Alpha-actinin-2, Z-disc component | Cross-links actin; important for Z-disc integrity |
| DES | Desmin, intermediate filament | Connects sarcomeres to cytoskeleton; mutations cause myofibrillar myopathy |
| PRKAA1/2 | AMPK catalytic subunits, energy sensor | Regulates metabolism and protein synthesis; affects sarcomere assembly |
| MTOR | mTOR kinase, growth signaling | Promotes protein synthesis; positive regulator of muscle growth |
| MYH6 | Myosin heavy chain, atrial isoform | Expressed in heart; involved in sarcomere assembly |
| TNNC1 | Troponin C, calcium-binding | Essential for calcium-dependent contraction |
| MYOZ2 | Myozenin-2, Z-disc protein | Modulates calcineurin signaling; linked to cardiomyopathy |
| CSRP3 | Muscle LIM protein, Z-disc | Involved in mechanosensing; mutations cause cardiomyopathy |
| BAG3 | Co-chaperone, Z-disc | Maintains sarcomere integrity; mutations cause myofibrillar myopathy |
| FLNC | Filamin C, actin cross-linking | Important for sarcomere stability; mutated in cardiomyopathies |
How Is positive regulation of sarcomere organization Regulated?
Positive regulation of sarcomere organization is controlled by a network of signaling pathways and biophysical cues. The mTOR pathway promotes protein synthesis and muscle growth, while AMPK acts as an energy sensor that can either support or inhibit assembly depending on metabolic status. Calcium signaling through ryanodine receptors modulates contraction and can influence sarcomere organization. Biophysical cues such as substrate stiffness and electrical stimulation can reprogram cells toward a cardiomyocyte-like phenotype with organized sarcomeres. Additionally, satellite cell dysfunction in neuromuscular disorders impairs muscle regeneration and sarcomere assembly, highlighting the role of stem cell populations in regulation.
positive regulation of sarcomere organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYBPC1 | Myogenic tremor, skeletal myopathy | Knock-in mouse with patient variant; iPSC-derived myocytes |
| MYH7 | Hypertrophic cardiomyopathy | CRISPR knockout in cardiomyocytes; patient iPSCs |
| TNNT2 | Dilated cardiomyopathy | Point mutation knock-in in zebrafish or mouse |
| RYR2 | Arrhythmogenic right ventricular cardiomyopathy | Knock-in mouse; calcium imaging |
| PRKAA1/2 | Metabolic cardiomyopathy | Conditional knockout in mouse heart; AMPK activator studies |
Cardiomyopathies
Mutations in sarcomeric genes such as MYH7, TNNT2, and MYBPC1 disrupt sarcomere organization and cause hypertrophic or dilated cardiomyopathies. Positive regulators of sarcomere organization are potential therapeutic targets to restore contractile function.
Skeletal myopathies and neuromuscular disorders
Satellite cell dysfunction contributes to impaired muscle regeneration in neuromuscular disorders, affecting sarcomere assembly. Myogenic tremor associated with MYBPC1 variants exemplifies how sarcomeric protein defects lead to motor dysfunction.
Heart regeneration and metabolic disorders
Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term heart regeneration, linking metabolic pathways to positive regulation of sarcomere organization. Targeting these pathways may enhance cardiac repair.
From positive regulation of sarcomere organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate sarcomere organization? | CRISPR knockout in iPSC-derived cardiomyocytes |
| Does a patient variant impair sarcomere assembly? | Point mutation knock-in in zebrafish or mouse |
| Can overexpression enhance sarcomere assembly? | Lentiviral overexpression in primary myocytes |
| What is the role of metabolic signaling? | Conditional knockout of AMPK/mTOR in mouse heart |
| How do biophysical cues affect assembly? | Substrate stiffness and electrical stimulation in vitro |
| What is the impact of satellite cell dysfunction? | Satellite cell-specific knockout in mouse models |
How to Study the positive regulation of sarcomere organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence microscopy | Sarcomere length, alignment, Z-disc density | Assessment of assembly in cardiomyocytes |
| RNA-seq | Transcriptional changes | Identification of regulated genes |
| Proteomics | Protein abundance and modifications | Quantification of sarcomeric proteins |
| Calcium imaging | Calcium transients | Excitation-contraction coupling |
| Traction force microscopy | Contractile force | Functional assessment of sarcomeres |
| CRISPR screen | Gene essentiality for sarcomere organization | Discovery of positive regulators |
| Live-cell imaging | Dynamic assembly | Real-time visualization of sarcomere formation |
Imaging-based assessment of sarcomere organization
Fluorescence microscopy with antibodies against sarcomeric proteins (e.g., alpha-actinin, myosin) allows quantification of sarcomere length, alignment, and Z-disc density. Live-cell imaging can track assembly dynamics in real time.
Transcriptomic and proteomic profiling
RNA-seq and proteomics identify genes and proteins whose expression changes during sarcomere assembly or in response to positive regulators. Differential gene expression analysis in scallops exposed to altered pH and temperature revealed muscle-related genes.
Functional contractility assays
Traction force microscopy and calcium imaging measure contractile function and calcium handling, providing functional readouts of sarcomere organization.
CRISPR screening and bioinformatics
Genome-wide CRISPR screens can identify positive regulators of sarcomere organization. Bioinformatics integration of screen hits with transcriptomic data prioritizes candidate pathways.
How CRISPR Can Be Used to Study GO:0060298 positive regulation of sarcomere organization
Knockout
CRISPR knockout of candidate positive regulators in iPSC-derived cardiomyocytes or skeletal myoblasts can test whether the gene is required for sarcomere organization. Loss of function typically results in disorganized sarcomeres and impaired contractility.
Point Mutation
Introducing patient-specific point mutations (e.g., in MYBPC1 or MYH7) via CRISPR allows modeling of sarcomere disorganization and testing of corrective strategies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into sarcomeric genes enables live-cell tracking of protein localization and assembly dynamics without altering function.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase expression of positive regulators to enhance sarcomere assembly, useful for regenerative studies.
How EDITGENE Supports positive regulation of sarcomere organization Research
Researchers studying positive regulation of sarcomere organization-related genes often need to determine whether a candidate gene is causally involved in sarcomere assembly or is merely correlated with the process. EDITGENE provides comprehensive CRISPR-based services to enable such causal studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of sarcomere organization research.
Frequently Asked Questions About positive regulation of sarcomere organization
What is GO:0060298?
GO:0060298 is the Gene Ontology term for positive regulation of sarcomere organization, a biological process that increases the rate, frequency or extent of myofibril assembly by organizing muscle actomyosin into sarcomeres.
What genes are involved in positive regulation of sarcomere organization?
Key genes include MYH7, ACTC1, TNNT2, MYBPC1, RYR2, TTN, and signaling regulators such as AMPK and mTOR.
How is sarcomere organization regulated?
It is regulated by signaling pathways (mTOR, AMPK), calcium signaling, biophysical cues, and satellite cell function.
What diseases are associated with defective sarcomere organization?
Cardiomyopathies, skeletal myopathies, and neuromuscular disorders are linked to defects in sarcomere organization.
What methods are used to study positive regulation of sarcomere organization?
Common methods include immunofluorescence microscopy, RNA-seq, proteomics, calcium imaging, and CRISPR screens.
Can CRISPR be used to study sarcomere organization?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators.
What is the role of MYBPC1 in sarcomere organization?
MYBPC1 encodes myosin binding protein C, and variants cause myogenic tremor, highlighting its role in sarcomere assembly.
How does calcium signaling affect sarcomere organization?
Ryanodine receptors mediate calcium release, which is essential for contraction and can influence sarcomere organization.
Is sarcomere organization important for heart regeneration?
Yes, oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term heart regeneration, linking metabolism to sarcomere assembly.
What cell models are used to study sarcomere organization?
iPSC-derived cardiomyocytes, skeletal myoblasts, and animal models such as zebrafish and mouse are commonly used.
Conclusion
Positive regulation of sarcomere organization (GO:0060298) is a fundamental biological process that ensures proper assembly of the contractile machinery in muscle cells. Dysregulation of this process underlies a spectrum of cardiac and skeletal muscle diseases, making it a critical area of research. Advances in CRISPR-based models and multi-omics approaches are accelerating the discovery of positive regulators and their therapeutic potential.
References
- 1. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 2. Lekkos K et al.. 2025. Oxidative phosphorylation is required for cardiomyocyte re-differentiation and long-term fish heart regeneration.. Nat Cardiovasc Res 4(10):1363-1380 PMID: 41034455
- 3. Benítez S et al.. 2023. Differential gene expression analysis in the scallop Argopecten purpuratus exposed to altered pH and temperature conditions in an upwelling-influenced farming area.. Comp Biochem Physiol Part D Genomics Proteomics 45:101046 PMID: 36495831
- 4. Grosberg A et al.. 2011. Self-organization of muscle cell structure and function.. PLoS Comput Biol 7(2):e1001088 PMID: 21390276
- 5. Sia J et al.. 2016. Effect of biophysical cues on reprogramming to cardiomyocytes.. Biomaterials 103:1-11 PMID: 27376554
- 6. Uneoka S et al.. 2023. A Case Series of Patients With MYBPC1 Gene Variants Featuring Undulating Tongue Movements as Myogenic Tremor.. Pediatr Neurol 146:16-20 PMID: 37392669
- 7. Rigg L et al.. 2000. Localisation and functional significance of ryanodine receptors during beta-adrenoceptor stimulation in the guinea-pig sino-atrial node.. Cardiovasc Res 48(2):254-64 PMID: 11054472
- 8. Lin GB et al.. 2019. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.. Math Biosci Eng 17(1):834-844 PMID: 31731380
